OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development

to co-finance international patent protection for the OAT449 group of compounds. The funding sources is Action 5.4.1 of the Innovative Economy Operational Programme and the value of the contract is approximately 0.4M PLN. “Grants fo innovation”